Скачать или смотреть CRISPR's Ethical Dilemma: Who Controls the Future of Human DNA? (EduChannel)

CRISPR technology has given humanity the power to edit life itself. We can now correct genetic diseases, but the greatest obstacles to this revolution aren't biological—they are ethical, economic, and political.

In this critical deep-dive, we move beyond the science to analyze the complex governance issues surrounding gene-editing therapies, drawing on expert research from the NIH, the Nuffield Council on Bioethics, and the ICER.

You will learn about:

The Ethical Red Line: We examine the profound moral debate over heritable gene editing (editing embryos) and the social consequences for future generations.

The Price Tag Problem: Why life-saving gene therapies come with astronomically high costs, and the innovative payment models (like subscription models) being proposed to manage the healthcare budget impact.

Safety vs. Hype: The crucial scientific realities, including the risk of chromosomal abnormalities and the need for meticulous safety governance (as highlighted by NIH reviews).

Patents and Power: How university patents and licensing agreements play a critical role in controlling access and maintaining the high prices of these revolutionary medical tools.

This video is essential for understanding the policies and economics that will determine whether gene editing becomes a universal cure or a luxury for the privileged few.

👍 Like this video if you believe ethics must guide innovation! 🔔 Subscribe to EduChannel for critical analysis on science, ethics, and global economics. 💬 Should life-saving gene therapies be priced to cover R&D, or should they be treated as a global common good? Share your thoughts below!

#CRISPR #GeneEditing #Bioethics #GeneTherapy #MedicalEconomics #Longevity #SciencePolicy #ICER #EduChannel